glp 1 or sglt2 SGLT-2 Inhibitors and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Combining glucagon-like peptide-1 receptor agonists

Pricing, medications, coaching, and doctor oversight analyzed

For laboratory and research use only.

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.

Designed to complement a structured nutrition and lifestyle approach

A recently published, randomized, placebo-controlled trial found a greater reduction in BMI z-score (0.22 SDs) in adolescents receiving liraglutide compared with placebo

The assumption is often that once a goal weight or certain lab numbers are reached, the hard part is over and the results will hold